Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05629195
Other study ID # foshan202271
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date December 30, 2023

Study information

Verified date November 2022
Source First People's Hospital of Foshan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the clinical effect of tunneled PICC by comparing the rate of complications of the two groups of patients (tunneled PICC vs conventional PICC).


Description:

In this study, tunneled PICC was compared with conventional PICC. Eligible subjects were randomly enrolled into the test group or control group by randomization (1:1), and observed and evaluated the occurrence of complications during and 7 ± 3 days, 30 ± 7 days, 60 ± 10 days, 90 ± 10 days, 120 ± 10 days (if any) after surgery and extubation at the end of treatment. To evaluate the clinical effect of tunneled PICC by comparing the rate of complications of the two groups of patients


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 356
Est. completion date December 30, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients = 18 years old; - Patients who need PICC catheterization according to the doctor's advice; - There is no history of venous thrombosis, compression or blockage of superior vena cava, severe coagulation dysfunction and other contraindications for PICC catheterization; - There is no serious cardiovascular disease, such as atrial fibrillation, pulmonary heart disease and other patients with abnormal P wave, and severe heart block before catheterization - Patients who have not participated in other clinical studies; - Patients who voluntarily participate in this clinical study and can cooperate with clinical follow-up Exclusion Criteria: - Known allergy to catheter material; - The puncture site has a history of infection, injury and radiotherapy; - The puncture site has a history of venous thrombosis or surgery; - Severe abnormal bleeding and coagulation function; - Superior vena cava compression syndrome; - Surgical side limbs of breast cancer patients undergoing radical mastectomy or axillary lymph node dissection; - The ipsilateral limb of the pacemaker and the arteriovenous fistula; - patient or her/his family members refuse to sign the informed consent form.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
tunneled PICC
PICC catheter is inserted into the superior vena cava through the upper brachial vein by establishing a subcutaneous tunnel

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
First People's Hospital of Foshan

Outcome

Type Measure Description Time frame Safety issue
Primary rate of PICC complications Including bleeding, subcutaneous congestion, lymphatic exudation, phlebitis (mechanical phlebitis, thrombophlebitis), infection (local infection, tunnel infection, catheter related blood flow infection), thrombus (symptomatic thrombus, asymptomatic thrombus), catheter ectopic, medical adhesive related skin damage, catheter damage and blockage, etc 120 days
Secondary time of PICC insertion Time from the start of skin disinfection to the end of dressing fixation 1 hour
Secondary Success rate of catheterization Judgment of successful catheterization: The catheterization is successful and the catheter is placed in an accurate position, that is, the tip of the catheter reaches within 1/3 of the lower part of the superior vena cava or near the junction of the right atrium. 1 hour
Secondary score of operation pain Wong Banker facial expression scale was used. This method uses 6 facial expressions from smile to cry to express the degree of pain: 0 points for no pain, 1 point for slight pain, 2 points for some pain, 3 points for very pain, 4 points for severe pain, and 5 points for unbearable pain 1 hour
Secondary rate of unplanned extubation Extubation after abnormal treatment 120 days
Secondary rate of difficulty in decannulation Probability of failure to pull out PICC due to vasospasm, adhesion with thrombus, wrapping of fibrin sheath, etc 120 days
See also
  Status Clinical Trial Phase
Recruiting NCT03897959 - COMPARISON OF KOHLI AND FOLEY CATHETERS IN SUPRAPUBIC CATHETER PATIENTS N/A